O	0	5	Acute	Acute	JJ	B-NP
O	6	14	ablation	ablation	NN	I-NP
O	15	17	of	of	IN	B-PP
B-Cell	18	28	Langerhans	Langerhan	NNPS	B-NP
I-Cell	29	34	cells	cell	NNS	I-NP
O	35	43	enhances	enhance	VBZ	B-VP
B-Organ	44	48	skin	skin	NN	B-NP
O	49	55	immune	immune	JJ	I-NP
O	56	65	responses	response	NNS	I-NP
O	65	66	.	.	.	O

O	67	80	Understanding	Understand	VBG	B-VP
O	81	84	the	the	DT	B-NP
O	85	93	function	function	NN	I-NP
O	94	96	of	of	IN	B-PP
B-Cell	97	107	Langerhans	Langerhans	NNP	B-NP
I-Cell	108	113	cells	cell	NNS	I-NP
O	114	115	(	(	(	O
B-Cell	115	118	LCs	LC	NNS	B-NP
O	118	119	)	)	)	O
O	120	122	in	in	FW	B-ADVP
O	123	127	vivo	vivo	FW	I-ADVP
O	128	131	has	have	VBZ	B-VP
O	132	136	been	be	VBN	I-VP
O	137	148	complicated	complicate	VBN	I-VP
O	149	151	by	by	IN	B-PP
O	152	163	conflicting	conflict	VBG	B-VP
O	164	171	results	result	NNS	B-NP
O	172	176	from	from	IN	B-PP
B-Cell	177	179	LC	LC	NN	B-NP
O	179	180	-	-	HYPH	B-NP
O	180	189	deficient	deficient	JJ	I-NP
O	190	194	mice	mouse	NNS	I-NP
O	194	195	.	.	.	O

O	196	201	Human	Human	JJ	B-NP
O	202	210	Langerin	Langerin	NN	I-NP
O	210	211	-	-	HYPH	B-NP
O	211	214	DTA	DTA	NN	I-NP
O	215	219	mice	mouse	NNS	I-NP
O	220	234	constitutively	constitutively	RB	B-ADVP
O	235	239	lack	lack	VBP	B-VP
B-Cell	240	243	LCs	LC	NNS	B-NP
O	244	247	and	and	CC	O
O	248	255	develop	develop	VB	B-VP
O	256	267	exaggerated	exaggerate	VBD	B-VP
O	268	275	contact	contact	NN	B-NP
O	276	292	hypersensitivity	hypersensitivity	NN	I-NP
O	293	294	(	(	(	O
O	294	297	CHS	CHS	NN	B-NP
O	297	298	)	)	)	O
O	299	308	responses	response	NNS	B-NP
O	308	309	.	.	.	O

O	310	316	Murine	Murine	JJ	B-NP
O	317	325	Langerin	Langerin	NN	I-NP
O	325	326	-	-	HYPH	I-NP
O	326	336	diphtheria	diphtheria	NN	I-NP
O	337	342	toxin	toxin	NN	I-NP
O	343	351	receptor	receptor	NN	I-NP
O	352	353	(	(	(	O
O	353	356	DTR	DTR	NN	B-NP
O	356	357	)	)	)	O
O	358	362	mice	mouse	NNS	B-NP
O	363	368	allow	allow	VBP	B-VP
O	369	372	for	for	IN	B-PP
O	373	376	the	the	DT	B-NP
O	377	386	inducible	inducible	JJ	I-NP
O	387	398	elimination	elimination	NN	I-NP
O	399	401	of	of	IN	B-PP
B-Cell	402	405	LCs	LC	NNS	B-NP
O	406	409	and	and	CC	O
B-Cell	410	418	Langerin	Langerin	NN	B-NP
I-Cell	418	419	(	(	(	O
I-Cell	419	420	+	+	SYM	O
I-Cell	420	421	)	)	)	O
I-Cell	422	428	dermal	dermal	JJ	B-NP
I-Cell	429	438	dendritic	dendritic	JJ	I-NP
I-Cell	439	444	cells	cell	NNS	I-NP
O	445	446	(	(	(	O
B-Cell	446	450	dDCs	dDC	NNS	B-NP
O	450	451	)	)	)	O
O	452	457	after	after	IN	B-PP
O	458	472	administration	administration	NN	B-NP
O	473	475	of	of	IN	B-PP
O	476	486	diphtheria	diphtheria	NN	B-NP
O	487	492	toxin	toxin	NN	I-NP
O	492	493	,	,	,	O
O	494	499	which	which	WDT	B-NP
O	500	507	results	result	VBZ	B-VP
O	508	510	in	in	IN	B-PP
O	511	518	reduced	reduce	VBN	B-NP
O	519	522	CHS	CHS	NN	I-NP
O	522	523	.	.	.	O

O	524	528	When	When	WRB	B-ADVP
B-Cell	529	537	Langerin	Langerin	NN	B-NP
I-Cell	537	538	(	(	(	O
I-Cell	538	539	+	+	SYM	O
I-Cell	539	540	)	)	)	O
I-Cell	541	545	dDCs	dDC	NNS	B-NP
O	546	550	have	have	VBP	B-VP
O	551	560	partially	partially	RB	I-VP
O	561	572	repopulated	repopulate	VBN	I-VP
O	573	576	the	the	DT	B-NP
B-Organ	577	581	skin	skin	NN	I-NP
O	582	585	but	but	CC	I-NP
B-Cell	586	589	LCs	LC	NNS	I-NP
O	590	593	are	be	VBP	B-VP
O	594	599	still	still	RB	B-ADVP
O	600	606	absent	absent	JJ	B-ADJP
O	606	607	,	,	,	O
O	608	611	CHS	CHS	NNP	B-NP
O	612	619	returns	return	NNS	I-NP
O	620	622	to	to	TO	B-PP
O	623	629	normal	normal	JJ	B-ADJP
O	629	630	.	.	.	O

O	631	635	Thus	Thus	RB	B-ADVP
O	635	636	,	,	,	O
B-Cell	637	640	LCs	LC	NNS	B-NP
O	641	647	appear	appear	VBP	B-VP
O	648	650	to	to	TO	I-VP
O	651	653	be	be	VB	I-VP
O	654	665	suppressive	suppressive	JJ	B-ADJP
O	666	668	in	in	IN	B-PP
O	669	674	human	human	JJ	B-NP
O	675	683	Langerin	Langerin	NN	I-NP
O	683	684	-	-	HYPH	B-NP
O	684	687	DTA	DTA	NN	I-NP
O	688	692	mice	mouse	NNS	I-NP
O	693	696	and	and	CC	O
O	697	706	redundant	redundant	JJ	B-ADJP
O	707	709	in	in	IN	B-PP
O	710	716	murine	murine	JJ	B-NP
O	717	725	Langerin	Langerin	NN	I-NP
O	725	726	-	-	HYPH	B-NP
O	726	729	DTR	DTR	NN	I-NP
O	730	734	mice	mouse	NNS	I-NP
O	734	735	.	.	.	O

O	736	738	To	To	TO	B-VP
O	739	748	determine	determine	VB	I-VP
O	749	756	whether	whether	IN	B-SBAR
O	757	766	inducible	inducible	JJ	B-ADJP
O	767	773	versus	versus	IN	B-PP
O	774	786	constitutive	constitutive	JJ	B-NP
B-Cell	787	789	LC	LC	NN	I-NP
O	790	798	ablation	ablation	NN	I-NP
O	799	807	explains	explain	VBZ	B-VP
O	808	813	these	these	DT	B-NP
O	814	821	results	result	NNS	I-NP
O	821	822	,	,	,	O
O	823	825	we	we	PRP	B-NP
O	826	836	engineered	engineer	VBD	B-VP
O	837	842	human	human	JJ	B-NP
O	843	851	Langerin	Langerin	NN	I-NP
O	851	852	-	-	HYPH	B-NP
O	852	855	DTR	DTR	NN	I-NP
O	856	860	mice	mouse	NNS	I-NP
O	861	863	in	in	IN	B-PP
O	864	869	which	which	WDT	B-NP
O	870	880	diphtheria	diphtheria	NN	B-NP
O	881	886	toxin	toxin	NN	I-NP
O	887	894	ablates	ablate	VBZ	B-VP
B-Cell	895	898	LCs	LC	NNS	B-NP
O	899	906	without	without	IN	B-PP
O	907	916	affecting	affect	VBG	B-VP
B-Cell	917	925	Langerin	Langerin	NN	B-NP
I-Cell	925	926	(	(	(	O
I-Cell	926	927	+	+	SYM	O
I-Cell	927	928	)	)	)	O
I-Cell	929	933	dDCs	dDC	NNS	B-NP
O	933	934	.	.	.	O

O	935	938	The	The	DT	B-NP
O	939	948	inducible	inducible	JJ	I-NP
O	949	957	ablation	ablation	NN	I-NP
O	958	960	of	of	IN	B-PP
B-Cell	961	964	LCs	LC	NNS	B-NP
O	965	967	in	in	IN	B-PP
O	968	973	human	human	JJ	B-NP
O	974	982	Langerin	Langerin	NN	I-NP
O	982	983	-	-	HYPH	B-NP
O	983	986	DTR	DTR	NN	I-NP
O	987	991	mice	mouse	NNS	I-NP
O	992	1000	resulted	result	VBD	B-VP
O	1001	1003	in	in	IN	B-PP
O	1004	1013	increased	increase	VBN	B-NP
O	1014	1017	CHS	CHS	NN	I-NP
O	1017	1018	.	.	.	O

O	1019	1023	Thus	Thus	RB	B-ADVP
O	1023	1024	,	,	,	O
B-Cell	1025	1027	LC	LC	NN	B-NP
O	1027	1028	-	-	HYPH	B-VP
O	1028	1036	mediated	mediate	VBN	B-NP
O	1037	1048	suppression	suppression	NN	I-NP
O	1049	1053	does	do	VBZ	B-VP
O	1054	1057	not	not	RB	I-VP
O	1058	1065	require	require	VB	I-VP
O	1066	1071	their	their	PRP$	B-NP
O	1072	1079	absence	absence	NN	I-NP
O	1080	1086	during	during	IN	B-PP
O	1087	1095	ontogeny	ontogeny	NN	B-NP
O	1096	1098	or	or	CC	B-PP
O	1099	1105	during	during	IN	B-PP
O	1106	1109	the	the	DT	B-NP
O	1110	1116	steady	steady	JJ	I-NP
O	1116	1117	-	-	HYPH	I-NP
O	1117	1122	state	state	NN	I-NP
O	1123	1126	and	and	CC	O
O	1127	1129	is	be	VBZ	B-VP
O	1130	1140	consistent	consistent	JJ	B-ADJP
O	1141	1145	with	with	IN	B-PP
O	1146	1147	a	a	DT	B-NP
O	1148	1153	model	model	NN	I-NP
O	1154	1156	in	in	IN	B-PP
O	1157	1162	which	which	WDT	B-NP
B-Cell	1163	1166	LCs	LC	NNS	B-NP
O	1167	1175	actively	actively	RB	B-ADVP
O	1176	1184	suppress	suppress	VBP	B-VP
O	1185	1187	Ag	Ag	NN	B-NP
O	1187	1188	-	-	HYPH	B-NP
O	1188	1196	specific	specific	JJ	I-NP
O	1197	1200	CHS	CHS	NN	I-NP
O	1201	1210	responses	response	NNS	I-NP
O	1210	1211	.	.	.	O

